<?xml version="1.0" encoding="UTF-8"?>
<p id="p0105">Regarding the protective effect of smoking, another cross-sectional study in France showed that current smokers are less likely to develop severe COVID-19 disease. They hypothesized a protective mechanism for nicotine, which binds to ACE2 receptors, preventing the SARS-CoV-2 virus from attaching, reducing the amount of virus that enters lung cells (
 <xref rid="bib25" ref-type="bibr">25</xref>). Like our study, several biases could be incurred due to the fact that the way in which the physician compiled the information classified the patient as a “smoker” is unknown. There is no information on the quantity, frequency, or time of evolution. Likewise, when questioned, and according to the severity of the clinic condition, patients can deny smoking to a health professional. Another type of research design is necessary to test this hypothesis.
</p>
